Ingrid Pabinger-fasching MD

Dr Ingrid Pabinger-Fasching was a Professor of Haemostaseology and Vice-Head of the Clinical Division of Haematology and Haemostaseology in the Department of Medicine I at the Medical University of Vienna, Austria. From 1997 to 2021 she was director of the haemostaseology outpatient department for adults at the Vienna General Hospital.

After graduating as Medical Doctor at the University of Vienna, Ingrid Pabinger went on to train in Internal Medicine, accomplishing her professorial dissertation (Habilitation) in 1991 and specializing in haematology and oncology in 1999. Part of her training she performed in one of the leading international research laboratories, working with Prof. Dr R.M. Bertina in Leiden, Holland. She started her career at the Department of Medicine I at the Vienna General Hospital and has been in charge of the Thrombosis and Haemostasis Research Group with a focus on thrombosis research and bleeding disorders since 1990. Her specific fields of expertise include hereditary and acquired thrombosis risk factors, cancer-associated thrombosis, haemophilia and acquired haemorrhagic diathesis, immune thrombocytopenia and specific coagulation problems in critically ill patients.

Ingrid Pabinger has been a Principal Investigator in many dozens of clinical trials and a Coordinating Investigator in several international studies. She has published more than 480 papers (as of March 2022) in peer-reviewed journals, mainly in the fields of thrombosis, haemostasis, haematology and internal medicine. She has worked as a Section- or Associate-Editor for several scientific journals, e.g. Haematologica, the Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Annals of Haematology and Thrombosis Research.

Ingrid Pabinger acted as President of the Annual Meeting of the German, Austrian and Swiss Society of Thrombosis and Haemostasis (GTH) in Vienna in 2009 and as Vice-President of the International Society on Thrombosis and Haemostasis (ISTH) Congress in Berlin in 2017. She has been involved in several international and national scientific societies throughout her career, including the Board of the GTH (Chairperson 2007–2011), the Board of the European Hematology Association (EHA), where she also chaired the Nomination Committee for Board Members, and international and scientific committees of the American Society of Hematology (ASH). For the period 2016-2018, she was President of the ISTH. In 2021 she became an Honorary Member of the Austrian Haemophilia Society, and in 2022 Honorary Member of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH).